Rimonabant: From RIO to Ban

• Główni autorzy: Amir H. Sam (Autor), Victoria Salem (Autor), Mohammad A. Ghatei (Autor)
• Format: Książka
• Wydane: Hindawi Limited, 2011-01-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Endocannabinoid antagonism as a treatment for obesity and the metabolic syndrome became a hugely anticipated area of pharmacology at the start of the century. The CB1 receptor antagonist Rimonabant entered the European mass market on the back of several trials showing weight loss benefits alongside...